{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T21:50:01Z","timestamp":1791582601329,"version":"4.3.4"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,9,3]],"date-time":"2027-09-03T00:00:00Z","timestamp":1819929600000},"content-version":"am","delay-in-days":276,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["1RO1HL163269"],"award-info":[{"award-number":["1RO1HL163269"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association Inc","doi-asserted-by":"publisher","award":["26PRE1561542"],"award-info":[{"award-number":["26PRE1561542"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of War","doi-asserted-by":"publisher","award":["HT942524PRMRPDA"],"award-info":[{"award-number":["HT942524PRMRPDA"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of War","doi-asserted-by":"publisher","award":["HT9425-25-1-0034"],"award-info":[{"award-number":["HT9425-25-1-0034"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.vph.2026.107693","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T15:25:32Z","timestamp":1788017132000},"page":"107693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pan-peroxisome proliferator-activated receptor agonist IVA337 alleviates secondary lymphedema via inhibiting TGF\u03b2\/SMAD2\/3 signaling pathway"],"prefix":"10.1016","volume":"165","author":[{"given":"Jingjing","family":"Pang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Long Nguyen Hoang","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Autieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2026.107693_bb0005","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1161\/CIRCRESAHA.121.318307","article-title":"Advances in lymphedema","volume":"128","author":"Rockson","year":"2021","journal-title":"Circ. Res."},{"issue":"2","key":"10.1016\/j.vph.2026.107693_bb0010","doi-asserted-by":"crossref","first-page":"330e","DOI":"10.1097\/PRS.0000000000009866","article-title":"The vicious circle of stasis, inflammation, and fibrosis in lymphedema","volume":"151","author":"Brown","year":"2023","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.vph.2026.107693_bb0015","series-title":"Lymphedema","article-title":"Epidemiology and morbidity of lymphedema","author":"Greene","year":"2015"},{"issue":"17","key":"10.1016\/j.vph.2026.107693_bb0020","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.192890","article-title":"TGF\u03b2-mediated epithelial-mesenchymal transition of keratinocytes promotes fibrosis in secondary lymphedema","volume":"10","author":"Park","year":"2025","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.vph.2026.107693_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.758","article-title":"TGF\u03b21 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation","volume":"12","author":"Baik","year":"2022","journal-title":"Clin. Transl. Med."},{"issue":"7","key":"10.1016\/j.vph.2026.107693_bb0030","doi-asserted-by":"crossref","first-page":"3907","DOI":"10.3390\/ijms25073907","article-title":"The role of inflammation in lymphedema: a narrative review of pathogenesis and opportunities for therapeutic intervention","volume":"25","author":"Bowman","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.vph.2026.107693_bb0035","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI71608","article-title":"New developments in clinical aspects of lymphatic disease","volume":"124","author":"Mortimer","year":"2014","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.vph.2026.107693_bb0040","doi-asserted-by":"crossref","first-page":"670","DOI":"10.5999\/aps.2021.01445","article-title":"Advances in surgical treatment of lymphedema","volume":"48","author":"Beederman","year":"2021","journal-title":"Arch. Plast. Surg."},{"key":"10.1016\/j.vph.2026.107693_bb0045","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/s41569-021-00569-6","article-title":"PPAR control of metabolism and cardiovascular functions","volume":"18","author":"Montaigne","year":"2021","journal-title":"Nat. Rev. Cardiol."},{"issue":"1","key":"10.1016\/j.vph.2026.107693_bb0050","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nrendo.2016.135","article-title":"PPARs in obesity-induced T2DM, dyslipidaemia and NAFLD","volume":"13","author":"Gross","year":"2017","journal-title":"Nat. Rev. Endocrinol."},{"issue":"4","key":"10.1016\/j.vph.2026.107693_bb0055","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1172\/JCI88894","article-title":"Distinct but complementary contributions of PPAR isotypes to energy homeostasis","volume":"127","author":"Dubois","year":"2017","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.vph.2026.107693_bb0060","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.vph.2026.107693_bb0065","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1172\/JCI10843","article-title":"Treatment of insulin resistance with peroxisome proliferator-activated receptor gamma agonists","volume":"106","author":"Olefsky","year":"2000","journal-title":"J. Clin. Invest."},{"issue":"12","key":"10.1016\/j.vph.2026.107693_bb0070","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1136\/annrheumdis-2015-208029","article-title":"Pan PPAR agonist IVA337 is effective in prevention and treatment of experimental skin fibrosis","volume":"75","author":"Ruzehaji","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.vph.2026.107693_bb0075","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.ajpath.2025.06.012","article-title":"Peroxisome proliferator-activated receptor agonist IVA337 alleviates inflammation and fibrosis in MASH by restoring lipid homeostasis","volume":"195","author":"Li","year":"2025","journal-title":"Am. J. Pathol."},{"issue":"17","key":"10.1016\/j.vph.2026.107693_bb0080","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the Pan-PPAR agonist Lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"24","key":"10.1016\/j.vph.2026.107693_bb0085","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.165324","article-title":"PPAR\u03b3 agonist treatment reduces fibroadipose tissue in secondary lymphedema by exhausting fibroadipogenic PDGFR\u03b1+ mesenchymal cell","volume":"8","author":"Chen","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.vph.2026.107693_bb0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s42000-024-00612-4","article-title":"PPARs: modulating lipotoxicity and thus inhibiting fibrosis","volume":"24","author":"Li","year":"2025","journal-title":"Hormones"},{"issue":"4","key":"10.1016\/j.vph.2026.107693_bb0095","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41421-018-0014-5","article-title":"Selective deletion of PPAR\u03b2\/\u03b4 in fibroblasts causes dermal fibrosis by attenuated LRG1 expression","author":"Sng","year":"2018","journal-title":"Cell Discov."},{"issue":"10","key":"10.1016\/j.vph.2026.107693_bb0100","doi-asserted-by":"crossref","first-page":"6321","DOI":"10.1021\/cr2001355","article-title":"PPARs and lipid ligands in inflammation and metabolism","volume":"111","author":"Harmon","year":"2011","journal-title":"Chem. Rev."},{"key":"10.1016\/j.vph.2026.107693_bb0105","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/nri912","article-title":"Emerging roles of PPARS in inflammation and immunity","volume":"2","author":"Daynes","year":"2002","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.vph.2026.107693_bb0110","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1038\/s42255-018-0030-7","article-title":"TGF-\u03b22 is an exercise-induced adipokine that regulates glucose and fatty acid metabolism","volume":"1","author":"Takahashi","year":"2019","journal-title":"Nat. Metab."},{"issue":"53","key":"10.1016\/j.vph.2026.107693_bb0115","doi-asserted-by":"crossref","first-page":"55104","DOI":"10.1074\/jbc.M407423200","article-title":"Vascular endothelial cell growth factor attenuates actions of transforming growth factor-\u03b2 in human endothelial cells","volume":"279","author":"Yamauchi","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.vph.2026.107693_bb0120","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/612089","article-title":"Peroxisome proliferator-activated receptor alpha target genes","volume":"2010","author":"Rakhshandehroo","year":"2010","journal-title":"PPAR Res."},{"key":"10.1016\/j.vph.2026.107693_bb0125","article-title":"Advances in etiology, pathophysiology, diagnosis, and management of lymphedema: a comprehensive review","volume":"12","author":"Wu","year":"2025","journal-title":"Front. Med. (Lausanne)."},{"issue":"19","key":"10.1016\/j.vph.2026.107693_bb0130","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1016\/j.cell.2023.07.036","article-title":"TGF\u03b2 signaling in health and disease","volume":"186","author":"Massagu\u00e9","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.vph.2026.107693_bb0135","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/s42255-019-0102-3","article-title":"Endothelial TGF\u03b2 signalling drives vascular inflammation and atherosclerosis","volume":"1","author":"Chen","year":"2019","journal-title":"Nat. Metab."},{"issue":"10","key":"10.1016\/j.vph.2026.107693_bb0140","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1084\/jem.20062596","article-title":"Functionally specialized junctions between endothelial cell of lymphatic vessels","volume":"204","author":"Baluk","year":"2007","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.vph.2026.107693_bb0145","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2025.1521320","article-title":"Characteristics and advances in signaling pathways, cellular communication, cell junctions, and oxidative stress in lymphedema","volume":"13","author":"Zhao","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"issue":"7","key":"10.1016\/j.vph.2026.107693_bb0150","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/cas.14457","article-title":"Potential role of transforming growth factor-beta 1\/Smad signaling in secondary lymphedema after cancer surgery","volume":"111","author":"Sano","year":"2020","journal-title":"Cancer Sci."},{"key":"10.1016\/j.vph.2026.107693_bb0155","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.828513","article-title":"Pharmacological treatment of secondary lymphedema","volume":"13","author":"Brown","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.vph.2026.107693_bb0160","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1089\/wound.2021.0041","article-title":"Current understanding of pathological mechanisms of lymphedema","volume":"11","author":"Sung","year":"2022","journal-title":"Adv. Wound. Care (New Rochelle)"},{"issue":"5","key":"10.1016\/j.vph.2026.107693_bb0165","doi-asserted-by":"crossref","first-page":"196","DOI":"10.3109\/08977194.2011.595714","article-title":"TGF\u03b2 signaling in fibrosis","volume":"29","author":"Biernacka","year":"2011","journal-title":"Growth Factors"},{"issue":"6","key":"10.1016\/j.vph.2026.107693_bb0170","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00011-019-01231-1","article-title":"Self-regulation of the inflammatory response by peroxisome proliferator-activated receptors","volume":"68","author":"Korbecki","year":"2019","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.vph.2026.107693_bb0175","article-title":"T-cell mesenchymal transition represents a potential pathogenic mechanism of female cancer-related lymphedema","author":"Wang","year":"2026","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.vph.2026.107693_bb0180","doi-asserted-by":"crossref","first-page":"518e","DOI":"10.1097\/PRS.0000000000005322","article-title":"Small numbers of CD4+ T cell can induce development of lymphedema","volume":"143","author":"Ly","year":"2019","journal-title":"Plast. Reconstr. Surg."},{"key":"10.1016\/j.vph.2026.107693_bb0185","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41586-025-10016-y","article-title":"Targeting excessive cholesterol deposition alleviates secondary lymphoedema","volume":"651","author":"Lim","year":"2026","journal-title":"Nature"},{"issue":"7639","key":"10.1016\/j.vph.2026.107693_bb0190","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nature21028","article-title":"The role of fatty acid \u03b2-oxidation in lymphangiogenesis","volume":"542","author":"Wong","year":"2017","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.vph.2026.107693_bb0195","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.3390\/cells11121935","article-title":"Regulation and dysregulation of endothelial permeability during systemic inflammation","volume":"11","author":"Hellenthal","year":"2022","journal-title":"Cells"},{"issue":"4","key":"10.1016\/j.vph.2026.107693_bb0200","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3390\/ijms26041708","article-title":"The interplay between immunity, inflammation and endothelial dysfunction","volume":"26","author":"Chee","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.vph.2026.107693_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2026.06.003","article-title":"TGF-\u03b21-induced endothelial transcytosis drives blood-brain barrier leakage during aging","author":"Fang","year":"2026","journal-title":"Neuron"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189126001138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:54:25Z","timestamp":1791579265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189126001138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":41,"alternative-id":["S1537189126001138"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2026.107693","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pan-peroxisome proliferator-activated receptor agonist IVA337 alleviates secondary lymphedema via inhibiting TGF\u03b2\/SMAD2\/3 signaling pathway","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2026.107693","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107693"}}